Buruli ulcer is a noncontagious disabling cutaneous and subcutaneous mycobacteriosis
reported by 33 countries in Africa, Asia, Oceania, and South America. The causative agent …

Mycobacterial diseases are a major public health challenge. Their causative agents include,
in order of impact, members of the Mycobacterium tuberculosis complex (causing …

Metabolomic profiling is an emerging field consisting of the measurement of metabolites in a
biological system. Since metabolites can vary in relation to different stimuli, specific …

Mycobacterium ulcerans causes Buruli Ulcer, a neglected infectious skin disease that
typically progresses from an early non-ulcerative lesion to an ulcer with undermined edges …

Atopic dermatitis is a chronic inflammatory disease which usually starts in the early
childhood and ends before adulthood. However up to 3% of adults remain affected by the …

Insulin resistance (IR), accompanied by an impaired cellular glucose uptake, characterizes
diverse pathologies that include, but are not limited to, metabolic disease, prediabetes and …

Abstract Background/Aim: Mycobacterium ulcerans causes the necrotizing skin disease
Buruli ulcer (BU), characterized by the formation of subcutaneous lesions and …

Buruli ulcer is an emerging infectious disease associated with high morbidity and
unpredictable outbreaks. It is caused by Mycobacterium ulcerans, a slow‐growing pathogen …

Background Buruli ulcer disease (BUD) caused by Mycobacterium (M.) ulcerans is
characterized by necrotic skin lesions. As for other mycobacterial infections, eg, tuberculosis …

Metabolomics concerns with the measurement and analysis of small molecule compounds
(< 1 kDa, eg amino acids, biogenic amines, carbohydrates, fatty acids, nucleic acids …